Clinical Trials Browser

Ovarian Cancer Recurrent × Bevacizumab × Clear all

NCT06843447 2026-05-26

MK-5909-003

Phase 1/2 Recruiting

Ovarian Cancer Recurrent

NCT04175470 2025-01-03

Bevacizumab and Tocotrienol in Recurrent Ovarian Cancer

Phase 2 Completed

Ovarian Cancer Recurrent